BBH vs IDNA

ABBH

BIDNA

Measures won4–2BBH wins · of 6 · 5Y

$10,000 · 5Y$13,520BBH · IDNA $8,568

Lowest cost0.35%BBH · $35 on $10k

Most income0.70%IDNA · $70 on $10k

Smallest drop−10.5%BBH · worst fall in 1Y

Held in common21.9%BBH and IDNA

VanEck Biotech ETF · $535MiShares Genomics Immunology and Healthcare ETF · $340M

+19.5%3 years · per year$17,046 · $21,676+29.4%

+6.2%5 years · per year$13,520 · $8,568−3.0%

0.35%Expense ratio$35 · $47 on $10k · lower wins0.47%

0.38%12-mo yield$38 · $70 on $10k0.70%

End-of-day Nov 13, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two

5Y2 funds

#			Trend
1	ABBH	VanEck Biotech ETFRead Desk		0.35%	0.38%	−0.7%	+33.5%	+34.4%	+19.5%	+6.2%	−10.5%	$535M
2	BIDNA	iShares Genomics Immunology and Healthcare ETFRead Desk		0.47%	0.70%	−1.9%	+53.8%	+54.1%	+29.4%	−3.0%	−10.6%	$340M

End-of-day Nov 13, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

5Y2 funds

#			Trend
1	ABBH	VanEck Biotech ETFRead Desk		0.35%	0.38%	−0.7%	+33.5%	+34.4%	+19.5%	+6.2%	−10.5%	$535M
2	BIDNA	iShares Genomics Immunology and Healthcare ETFRead Desk		0.47%	0.70%	−1.9%	+53.8%	+54.1%	+29.4%	−3.0%	−10.6%	$340M

End-of-day Nov 13, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

Cards for this view

BBH

VanEck Biotech

$13,520

IDNA

iShares Genomics Immunology and Healthcare

$8,568

Loading…